AnaptysBio, Inc.

ANAB

$48.53

Name : AnaptysBio, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,450,816,128.00

EPSttm : -0.96

AnaptysBio, Inc.

$48.53

0.31%

$0.15

ANAB — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

19.31

Margin Of Safety %

Put/Call OI Ratio

1.12

EPS Next Q Diff

1.17

EPS Last/This Y

EPS This/Next Y

0.34

Price

48.42

Target Price

79.71

Analyst Recom

1.14

Performance Q

-15.09

Upside

73.3%

Beta

0.86

Ticker: ANAB

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	ANAB	46	0.49	0.09	3532
2026-10-13	ANAB	45.59	0.48	2.95	3556
2026-10-14	ANAB	46.54	0.50	5.50	3602
2026-10-15	ANAB	48.68	0.50	17.00	3604
2026-10-16	ANAB	46.68	0.50	999.99	3608
2026-10-19	ANAB	49.28	0.51	0.53	3413
2026-10-20	ANAB	45.28	0.51	2.45	3489
2026-10-21	ANAB	47.92	0.53	0.44	3560
2026-10-22	ANAB	48.11	1.00	999.99	3167
2026-10-23	ANAB	48.7	1.01	7.73	3177
2026-10-26	ANAB	48.74	1.04	0.50	3225
2026-10-27	ANAB	49.74	1.04	0.06	3227
2026-10-28	ANAB	50.46	1.04	2.54	3223
2026-10-29	ANAB	48.65	1.08	1.30	3402
2026-10-30	ANAB	48.29	1.07	999.99	3429
2026-11-02	ANAB	47.08	1.10	11.50	3470
2026-11-03	ANAB	47.78	1.13	0.40	3512
2026-11-04	ANAB	47.6	1.12	1.75	3515
2026-11-05	ANAB	45.58	1.11	6.00	3515
2026-11-06	ANAB	46.46	1.11	0.25	3511
2026-11-09	ANAB	47.98	1.11	5.13	3516
2026-11-10	ANAB	48.42	1.12	7.00	3539
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	ANAB	46.03	53.1	-64.8	4.35
2026-10-13	ANAB	45.67	53.1	-66.7	4.35
2026-10-14	ANAB	46.58	53.1	-61.3	4.35
2026-10-15	ANAB	48.66	53.1	-53.3	4.35
2026-10-16	ANAB	46.58	53.1	-72.6	4.35
2026-10-19	ANAB	49.26	53.1	-55.4	4.35
2026-10-20	ANAB	49.26	53.1	-55.4	4.35
2026-10-21	ANAB	45.43	53.1	-69.5	4.35
2026-10-22	ANAB	48.11	53.1	-64.4	4.35
2026-10-23	ANAB	48.77	53.1	-64.4	4.35
2026-10-26	ANAB	48.76	53.1	-64.9	4.35
2026-10-27	ANAB	49.66	53.1	-61.7	4.20
2026-10-28	ANAB	50.46	53.1	-59.1	4.20
2026-10-29	ANAB	48.62	53.1	-71.5	4.20
2026-10-30	ANAB	48.30	2.1	-66.2	4.20
2026-11-02	ANAB	47.04	2.1	-69.5	4.20
2026-11-03	ANAB	47.81	2.1	-66.8	4.20
2026-11-04	ANAB	47.56	2.1	-65.7	4.20
2026-11-05	ANAB	45.58	2.1	-72.2	4.20
2026-11-06	ANAB	46.47	2.1	-61.5	4.20
2026-11-09	ANAB	47.93	2.1	-59.7	4.20
2026-11-10	ANAB	48.42	2.1	-63.4	4.20
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	ANAB	-0.25	5.57	18.77
2026-10-13	ANAB	-0.25	5.57	18.77
2026-10-14	ANAB	-0.25	5.57	18.77
2026-10-15	ANAB	-0.25	5.57	18.77
2026-10-16	ANAB	-0.25	5.57	18.75
2026-10-19	ANAB	-0.25	5.61	18.75
2026-10-20	ANAB	-0.25	5.61	18.75
2026-10-21	ANAB	-0.25	5.61	18.75
2026-10-22	ANAB	-0.25	5.61	18.75
2026-10-23	ANAB	-0.25	5.61	18.75
2026-10-26	ANAB	-0.25	4.79	18.75
2026-10-27	ANAB	-0.25	4.79	19.31
2026-10-28	ANAB	-0.25	4.79	19.31
2026-10-29	ANAB	-0.25	4.79	19.31
2026-10-30	ANAB	-0.25	4.79	19.31
2026-11-02	ANAB	-0.25	5.15	19.31
2026-11-03	ANAB	-0.25	5.15	19.31
2026-11-05	ANAB	-0.25	5.15	19.31
2026-11-06	ANAB	-0.25	5.15	19.31
2026-11-09	ANAB	-0.25	4.15	19.31
2026-11-10	ANAB	-0.25	4.15	19.31
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.11

Avg. EPS Est. Current Quarter

0.53

Avg. EPS Est. Next Quarter

1.06

Insider Transactions

-0.25

Institutional Transactions

4.15

Beta

0.86

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

33.1

Max Drawdown 5-Year %

-69.3

Target Price

79.71

P/E

7.51

Forward P/E

PEG

P/S

6.09

P/B

135.88

P/Free Cash Flow

80.04

EPS

6.45

Average EPS Est. Cur. Y

4.2

EPS Next Y. (Est.)

4.54

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

82.37

Relative Volume

0.51

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.58

EBIT Estimation

-63.4

◆ ANAB Healthcare

$48.38

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

13/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

0/10

RSI

49.8

Range 1M

52%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

14/30

Estimates

6/20

Inst/Vol

5/15

Options

0/10

EPS Yr

EPS NY

52W%

52.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +34.2% upside

Quality

13/30

Valuation

10/30

Growth

9/25

Stability

6/10

LT Trend

0/5

Upside

+34.2%

Quality

ANAB — P/E HistoricalBiotechnology

AnaptysBio, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees:

AnaptysBio, Inc. discovers and out-licenses therapeutic bodies in the United States. The company manages financial collaborations for Jemperli, a PD-1 antagonist for various solid tumor indications; and Quimilza, an IL-36R antagonist mAb, which has completed two registration-enabling global Phase 3 trials, and GEMINI-1 and GEMINI-2, evaluating the safety and efficacy of Quimilza in patients with generalized pustular psoriasis. It has a collaboration and exclusive license agreement with GSK plc to develop Jemperli as a monotherapy; and an exclusive license agreement with Vanda Pharmaceuticals Inc. for the development and commercialization of Quimilza. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

ANAB

Latest News

—

Caricamento notizie per ANAB…

stock quote shares ANAB – AnaptysBio Inc Stock Price stock today

news today ANAB – AnaptysBio Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ANAB – AnaptysBio Inc yahoo finance google finance

stock history ANAB – AnaptysBio Inc invest stock market

stock prices ANAB premarket after hours

ticker ANAB fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ANAB

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y